Mylan is looking to set up its own pharmacy to cut out middlemen and enable the drugmaker to sell EpiPens directly to public places, says a Bloomberg article.
Mylan wants to sell the product to public places, such as restaurants, hotels and sports venues, bypassing pharmacies and chains such as CVS and Walgreens, according to a plan obtained by Bloomberg News through public records requests.
Mylan is pursuing strategy that pushes for state laws to allow these "entity" prescriptions -- drugs sold to places rather than people -- and, if successful, could revolutionize an industry whose layers of middlemen are said to be partly responsible for higher costs faces by consumers.
Read the Bloomberg article